Found 6 matching trials
Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer PHASE2 This is a prospective, single-arm, single-center Phase II clinical study. I...
Show More Learn More & Join Trial
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer PHASE1 Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Show More Location
Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer PHASE2 An Exploratory, Multi-cohort Phase II Study of combination therapy of AK112...
Show More Location
Union Hospital Tongji Medical College Huazhong University of Science And Technology
Learn More & Join Trial
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk PHASE4 This study is a single-arm, open-label study. To assess the efficacy and sa...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 This trial aims to study the role of Ivonescimab combined with chemoradioth...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression PHASE2 This is a prospective, single-arm, multi-center, phase II clinical trial to...
Show More Location
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
Learn More & Join Trial